HBA1 and HBA2 genes
OMIM#604131 https://omim.org/entry/604131
1. The disease:
A rare inherited hemoglobinopathy characterized by impaired synthesis of two to all four alpha-globin chains leading to a variable clinical picture depending on the number of affected alleles.
2. The symptoms:
Disease expression varies according to the level of alpha-globin chain deficiency. Lack of early signs or symptoms does not exclude the diagnosis.
- Alpha-thalassemia 2 or alpha+-thalassemia causes mild anemia (often detected on routine blood tests), generally with no other symptoms.
- Alpha-thalassemia 1 or alpha0-thalassemia can present as the most severe form Hb Bart’s hydrops fetalis involves a severe deficiency in alpha-globin chains with serious developmental implications.
- A combination of the molecular basis of alpha-thalassemia 2 and alpha-thalassemia 1 can cause Haemoglobin H disease (HbH), which is characterized by moderate hemolytic anemia with variable amounts of hemoglobin H along with occasionally severe splenomegaly, sometimes complicated by hypersplenism and necessity of transfusions.
3. Actions to take in case of early diagnosis:
- Correlation with other exams as hematologic testing of red blood cell (RBC), peripheral blood smear, supravital stain to detect RBC inclusion bodies, and qualitative and quantitative haemoglobin analysis is important.
- Alpha-thalassemia is a lifelong disease requiring lifetime management and regular follow-up with a Haematology Center.
- Specific treatment is required and may include occasional or regular red blood cell transfusions, iron chelation, and other supportive measures.
- Neonates with Hb Bart’s hydrops fetalis usually have a severe presentation. In patients with haemoglobin H disease, the prognosis is usually good, but depends on complications and care.
- The pattern of inheritance is autosomal recessive and genetic counselling should be offered to at-risk family members.
4. For more information:
Biblio :
- https://www.ncbi.nlm.nih.gov/books/NBK1435/
- Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K. Update in Laboratory Diagnosis of Thalassemia. Front Mol Biosci. 2020;7:74. PMID:32671092.